Nevertheless, the overall diagnostic performance of IGFBP-7 and TIMP-2 remains consistent across studies, underscoring their reliability as biomarkers for renal dysfunction in multiple myeloma [14]. The gene discussed is IGFBP7; the disease is plasma cell myeloma.